Charles Schwab Investment Management »

Carisma Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Carisma Therapeutics (CARM) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Carisma Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Carisma Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carisma Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $213k 73k 2.93
2023-09-30 $308k 73k 4.23
2023-06-30 $638k 73k 8.77